| 51 |
10638896 | Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury. | 2000 Jan |
2 |
| 52 |
10839906 | The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium. | 2000 Jun |
4 |
| 53 |
10910502 | Cholinesterase inhibition by potato glycoalkaloids slows mivacurium metabolism. | 2000 Aug |
1 |
| 54 |
10969512 | Prolonged neuromuscular block with mivacurium in a patient with cholinesterase deficiency. | 2000 Aug |
1 |
| 55 |
10223167 | Clinical pharmacokinetics of the newer neuromuscular blocking drugs. | 1999 Mar |
1 |
| 56 |
10487141 | The infusion rate of mivacurium or atracurium for cesarean section compared with gynecological procedures. | 1999 Aug |
1 |
| 57 |
10540097 | Organophosphorus poisoning and anaesthesia. | 1999 Nov |
1 |
| 58 |
10548961 | [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses]. | 1999 Oct |
1 |
| 59 |
9428856 | Postpartum patients have slightly prolonged neuromuscular block after mivacurium. | 1998 Jan |
1 |
| 60 |
9742542 | Prolonged mivacurium neuromuscular block in children. | 1998 |
1 |
| 61 |
9768768 | Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults. | 1998 Oct |
1 |
| 62 |
9806709 | Prolonged paralysis after a test dose of mivacurium in a patient with atypical serum cholinesterase. | 1998 Nov |
1 |
| 63 |
9834800 | Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity? | 1998 Nov |
1 |
| 64 |
9861140 | Mivacurium compared with succinylcholine in children with liver disease. | 1998 Sep |
1 |
| 65 |
9024049 | Markedly prolonged paralysis after mivacurium in a patient apparently heterozygous for the atypical and usual pseudocholinesterase alleles by conventional biochemical testing. | 1997 Feb |
1 |
| 66 |
9133184 | [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade]. | 1997 Feb |
1 |
| 67 |
9161749 | Natural inhibitors of cholinesterases: implications for adverse drug reactions. | 1997 May |
1 |
| 68 |
9176596 | Mivacurium. | 1997 Mar 5-18 |
1 |
| 69 |
9195358 | Pseudocholinesterase hyperactivity with succinylcholine resistance: an unusual cause of difficult intubation. | 1997 Jun |
1 |
| 70 |
9241338 | The effect of halothane on mivacurium infusion requirements in adult surgical patients. | 1997 Jun |
1 |
| 71 |
9245207 | [The clinical pharmacology of mivacurium]. | 1997 May |
2 |
| 72 |
9424685 | [Mivacurium]. | 1997 Oct |
1 |
| 73 |
9466100 | Mivacurium or vecuronium for muscular relaxation in day-case surgery. | 1997 Nov |
1 |
| 74 |
8638786 | The neuromuscular effects of mivacurium chloride during propofol anesthesia in children. | 1996 Jun |
1 |
| 75 |
8638849 | Pseudocholinesterase-mediated hydrolysis is superior to neostigmine for reversal of mivacurium-induced paralysis in vitro. | 1996 Apr |
4 |
| 76 |
8695079 | Cumulative reduction in serum cholinesterase following repeated therapeutic plasma exchange. | 1996 Feb |
1 |
| 77 |
8712423 | Does age or pseudocholinesterase activity predict mivacurium infusion rate in children? | 1996 Jan |
3 |
| 78 |
8868525 | [New muscle relaxants]. | 1996 Feb |
2 |
| 79 |
8889423 | Extended neuromuscular blockade with mivacurium following pancuronium. | 1996 Sep |
1 |
| 80 |
8922768 | The reversal of profound mivacurium-induced neuromuscular blockade. | 1996 Nov |
2 |
| 81 |
8949825 | Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block. | 1996 Sep |
2 |
| 82 |
8955970 | Neostigmine but not edrophonium prolongs the action of mivacurium. | 1996 Dec |
2 |
| 83 |
8970294 | Plasma cholinesterase deficiency. | 1996 Oct |
1 |
| 84 |
7486808 | Mivacurium sensitivity in a patient heterozygous for the atypical and silent genes for plasma cholinesterase. | 1995 Jul |
1 |
| 85 |
7574048 | Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase. | 1995 Oct |
1 |
| 86 |
7717563 | Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. | 1995 Apr |
1 |
| 87 |
7734267 | Effect of renal function on neuromuscular block induced by continuous infusion of mivacurium. | 1995 Apr |
1 |
| 88 |
7741305 | Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. | 1995 May |
1 |
| 89 |
7741307 | Reversal of intense mivacurium block with human plasma cholinesterase in patients with atypical plasma cholinesterase. | 1995 May |
2 |
| 90 |
7762834 | Changes in plasma cholinesterase activity and mivacurium neuromuscular block in response to normothermic cardiopulmonary bypass. | 1995 Jun |
2 |
| 91 |
7893031 | The effect of plasma cholinesterase activity on mivacurium infusion rates. | 1995 Apr |
1 |
| 92 |
8533547 | Mivacurium chloride administration by infusion. | 1995 |
1 |
| 93 |
8533937 | Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase. | 1995 Dec |
1 |
| 94 |
8607297 | Mivacurium block in patients with abnormal plasma cholinesterase. | 1995 Nov |
1 |
| 95 |
8607300 | Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity. | 1995 Nov |
2 |
| 96 |
8745974 | [Prolonged neuromuscular block after mivacurium injection]. | 1995 |
1 |
| 97 |
8745975 | [Prolonged neuromuscular block after administration of mivacurium caused by plasma psueudocholinesterase deficiency]. | 1995 |
1 |
| 98 |
7710221 | Clinical importance of plasma cholinesterase for the anaesthetist. | 1994 Nov |
1 |
| 99 |
8159634 | Newer neuromuscular blocking agents. | 1994 Jan |
1 |
| 100 |
7691494 | Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia. | 1993 Jun |
2 |